Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses

PR Newswire September 12, 2017

Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017

PR Newswire September 6, 2017

Investor Network: Aethlon Medical, Inc. to Host Earnings Call

Accesswire August 10, 2017

Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017

PR Newswire August 3, 2017

Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes

PR Newswire July 19, 2017

Aethlon Medical Announces Fiscal 2017 Results

PR Newswire June 28, 2017

Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017

PR Newswire June 26, 2017

Aethlon Medical To Present Clinical Study Results at The BIO International Convention

PR Newswire June 14, 2017

Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017

PR Newswire June 6, 2017

Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017

PR Newswire May 24, 2017

Aethlon Medical Releases Shareholder Update

PR Newswire April 24, 2017

Aethlon Medical Discloses Tech Nation Interview On National Public Radio

PR Newswire April 4, 2017

Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study

PR Newswire March 13, 2017

Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017

PR Newswire March 8, 2017

Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes

PR Newswire March 1, 2017

Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism

PR Newswire February 24, 2017

Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies

PR Newswire February 22, 2017

Aethlon Medical Announces Fiscal 2017 Third Quarter Results

PR Newswire February 10, 2017

Earnings Scheduled For February 10, 2017

Benzinga.com  February 10, 2017

Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017

PR Newswire February 6, 2017